M Gébus1, J-L Michel2, S Samperiz1, L Harper2, J-L Alessandri2, D Ramful1. 1. Service de Réanimation Néonatale et Infantile, CHU Felix Guyon de la Réunion, Saint-Denis, France. 2. Service de Chirurgie Pédiatrique, CHU Félix Guyon de la Réunion, Saint-Denis, France.
Abstract
OBJECTIVE: To describe conservative management of spontaneous intestinal perforation (SIP) in preterm infants using peritoneal needle aspiration (PNA). STUDY DESIGN: Monocentric retrospective review of SIP cases treated primarily by PNA between 1999 and 2015 (n=31). RESULTS: Mean gestational age was 29.2±2.4 weeks and birthweight 1149±428 g. SIP occurred at 3.7±2.2 days of life. PNA achieved definitive treatment in 18 patients (60%) with a mean of 1.8 (±0.8) procedures. All patients requiring more than three PNAs had secondary laparotomy. Two patients died and five presented severe cerebral lesions. Full enteral feeding was achieved 42±18 days after SIP. Intestinal morbidity included cholestasis (n=6), intestinal stricture (n=1) and growth restriction (n=22). On follow-up (n=25, median=4 years), no severe impairment was noted. Seventeen children (68%) had a normal development. CONCLUSION: PNA as primary therapy for SIP is a viable option, resulting in definitive treatment in 60% of cases, with limited mortality and morbidity.
OBJECTIVE: To describe conservative management of spontaneous intestinal perforation (SIP) in preterm infants using peritoneal needle aspiration (PNA). STUDY DESIGN: Monocentric retrospective review of SIP cases treated primarily by PNA between 1999 and 2015 (n=31). RESULTS: Mean gestational age was 29.2±2.4 weeks and birthweight 1149±428 g. SIP occurred at 3.7±2.2 days of life. PNA achieved definitive treatment in 18 patients (60%) with a mean of 1.8 (±0.8) procedures. All patients requiring more than three PNAs had secondary laparotomy. Two patients died and five presented severe cerebral lesions. Full enteral feeding was achieved 42±18 days after SIP. Intestinal morbidity included cholestasis (n=6), intestinal stricture (n=1) and growth restriction (n=22). On follow-up (n=25, median=4 years), no severe impairment was noted. Seventeen children (68%) had a normal development. CONCLUSION: PNA as primary therapy for SIP is a viable option, resulting in definitive treatment in 60% of cases, with limited mortality and morbidity.
Authors: A R Stark; W A Carlo; J E Tyson; L A Papile; L L Wright; S Shankaran; E F Donovan; W Oh; C R Bauer; S Saha; W K Poole; B J Stoll Journal: N Engl J Med Date: 2001-01-11 Impact factor: 91.245
Authors: T A Shah; J Meinzen-Derr; T Gratton; J Steichen; E F Donovan; K Yolton; B Alexander; V Narendran; K R Schibler Journal: J Perinatol Date: 2011-12-08 Impact factor: 2.521
Authors: Martin L Blakely; Kevin P Lally; Scott McDonald; Rebeccah L Brown; Douglas C Barnhart; Richard R Ricketts; W Raleigh Thompson; L R Scherer; Michael D Klein; Robert W Letton; Walter J Chwals; Robert J Touloukian; Arlett G Kurkchubasche; Michael A Skinner; R Lawrence Moss; Mary L Hilfiker Journal: Ann Surg Date: 2005-06 Impact factor: 12.969
Authors: Martin L Blakely; Jon E Tyson; Kevin P Lally; Scott McDonald; Barbara J Stoll; David K Stevenson; W Kenneth Poole; Alan H Jobe; Linda L Wright; Rosemary D Higgins Journal: Pediatrics Date: 2006-03-20 Impact factor: 7.124